Brain Derived Neurotrophic Factor (BDNF) Gene in Peripheral Blood Cells of Stable Schizophrenia
DOI:
https://doi.org/10.31436/imjm.v21i1.1840Keywords:
Epigenetics, DNA methylation,, schizophrenia, BDNFAbstract
INTRODUCTION: Epigenetic mechanisms regulate gene functions without causing a change in the nucleotide sequence of DNA. Brain-derived neurotrophic factor (BDNF) is a neurotrophin that regulates synaptic transmission and plasticity and has an essential role in neurodevelopment. Collected evidence suggests that epigenetic changes in the BDNF gene are related to the pathophysiology of psychiatric disorders such as schizophrenia. Therefore, the aim of this study was to assess the association of BDNF DNA methylation with schizophrenia. In addition, the relationship between BDNF DNA methylation and antipsychotics was studied. MATERIALS AND METHODS: Overall, 118 (88 male and 30 female) schizophrenia patients and 122 (92 male and 30 female) healthy controls were included in the study and methylation status was investigated using the Methylight Taqman® assay. RESULTS: There was no significant change in the DNA methylation status between schizophrenia patients and controls in this study despite its increased level (p=0.073). However, DNA methylation level was associated with sex and the difference was more significantly prominent in the male subjects (p=0.016). In addition, BDNF DNA methylation showed a positive significant correlation with the positive symptoms (p=0.032) of schizophrenia and antipsychotics use (p=0.013). CONCLUSION: The BDNF DNA methylation could be affected by gender and has a clinical association.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
All material submitted for publication is assumed to be submitted exclusively to the IIUM Medical Journal Malaysia (IMJM) unless the contrary is stated. Manuscript decisions are based on a double-blinded peer review process. The Editor retains the right to determine the style and if necessary, edit and shorten any material accepted for publication.
IMJM retain copyright to all the articles published in the journal. All final ‘proof’ submissions must be accompanied by a completed Copyright Assignment Form, duly signed by all authors. The author(s) or copyright owner(s) irrevocably grant(s) to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the research article in its entirety or in part, in any format or medium, provided that no substantive errors are introduced in the process, proper attribution of authorship and correct citation details are given, and that the bibliographic details are not changed. If the article is reproduced or disseminated in part, this must be clearly and unequivocally indicated.